Relapse After Frontline BTKi Therapy in Patients with CLL: Options and Consideration

被引：0
|
作者：
Lamanna, Nicole [1 ]
机构：
[1] Columbia Univ, Med Ctr, New York, NY USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
Chronic lymphocytic leukemia; relapsed after BTKi therapy; venetoclax; CHRONIC LYMPHOCYTIC-LEUKEMIA; VENETOCLAX; IBRUTINIB; OUTCOMES; ACALABRUTINIB; RESISTANCE; RITUXIMAB;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EXABS-124-
引用
收藏
页码：S40 / S42
页数：3
相关论文
共 50 条
  • [31] Booster and BTKi Interruption Improve Response to SARS-CoV-2 Vaccine in Patients With CLL
    Bryer, Emily
    Paul, Shira
    Chen, Jonathan
    Pleyer, Christopher
    Wiestner, Adrian
    Sun, Clare
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S270 - S271
  • [32] Determinants of relapse after electroconvulsive therapy in depressed patients
    Grueter, Jonas
    Groezinger, Michael
    [J]. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2018, 86 (11) : 711 - 717
  • [33] RELAPSE OF TULAREMIA AFTER AMINOGLYCOSIDE THERAPY - CASE-REPORT AND DISCUSSION OF THERAPEUTIC OPTIONS
    RISI, GF
    POMBO, DJ
    [J]. CLINICAL INFECTIOUS DISEASES, 1995, 20 (01) : 174 - 175
  • [34] POINT Is a BTKi or BCL2i preferable for first "novel" therapy in CLL? The case for BTKis
    Brem, Elizabeth A.
    O'Brien, Susan
    [J]. BLOOD ADVANCES, 2022, 6 (04) : 1361 - 1364
  • [35] SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab
    Marques-Piubelli, Mario L.
    Parra, Edwin R.
    Feng, Lei
    Soto, Luisa Solis
    Gallardo, Mariana
    Gouni, Sushanth
    Samaniego, Felipe
    Noorani, Mansoor
    Hagemeister, Fredrick B.
    Westin, Jason R.
    Lee, Hun Ju
    Rodriguez, Maria A.
    Neelapu, Sattva S.
    Gunther, Jillian R.
    Fowler, Nathan H.
    Flowers, Christopher R.
    Wistuba, Ignacio I.
    Nastoupil, Loretta J.
    Vega, Francisco
    Strati, Paolo
    [J]. BLOOD ADVANCES, 2022, 6 (11) : 3286 - 3293
  • [36] Multiple Options: How to Choose Therapy in Frontline Metastatic Melanoma
    Kennedy, Lucy Boyce
    Salama, April K. S.
    [J]. CURRENT ONCOLOGY REPORTS, 2024, 26 (08) : 915 - 923
  • [37] Booster and Btki Interruption Improve Response to Sars-Cov-2 Vaccine in Patients with CLL
    Bryer, Emily
    Paul, Shira
    Chen, Jonathan
    Pleyer, Christopher
    Wiestner, Adrian
    Sun, Clare
    [J]. BLOOD, 2022, 140 : 9896 - 9897
  • [38] Improving Outcomes After Frontline Therapy
    Hennessy, Mike, Sr.
    [J]. ONCOLOGY-NEW YORK, 2021, 35 (06): : 298 - 298
  • [39] A study of frontline therapy in adults >80 years with chronic lymphocytic leukemia (CLL)
    Tsang, Mazie
    Hampel, Paul Joseph
    Rabe, Kari G.
    Ding, Wei
    Leis, Jose Francisco
    Kenderian, Saad
    Wang, Yucai
    Muchtar, Eli
    Koehler, Amber
    Hanson, Curtis A.
    Shi, Min
    Slager, Susan L.
    Kay, Neil E.
    Parikh, Sameer Ashok
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [40] PBSC transplantation in CLL patients in remission after fludarabine therapy.
    Meloni, G
    Mauro, F
    Proia, A
    Capria, S
    Cordone, I
    De Fabritiis, P
    Foa, R
    Pescarmona, E
    Spirito, F
    Mandelli, F
    [J]. BONE MARROW TRANSPLANTATION, 1998, 21 : S79 - S79
12345